title: New-onset maternal gestational hypertension and risk of retinopathy of prematurity.
abstract: OBJECTIVE
  To evaluate associations between conditions of maternal new-onset gestational hypertension (mHTN) and the features imparting risk of severe retinopathy of prematurity (ROP) in preterm infants.
  
  
  METHODS
  Hospital databases and charts of all preterm inborn infants at the University of North Carolina from 1996 to 2007 were retrospectively reviewed. The presence or absence of mHTN (e.g., pre-eclampsia) and infant factors (birthweight, gestational age, erythropoietin use, and zone and stage of ROP) were analyzed for independence of association.
  
  
  RESULTS
  Of the 5143 infants, 323 had ROP and 76 had mothers with mHTN. Infants with ROP were more likely to have mothers with mHTN and to be younger and smaller at birth. At initial examination, more infants of mothers with mHTN had vascularization into the lower zones than did infants of mothers without mHTN (P < 0.001). However, at the examination in which the most severe ROP was present, there was no association between mHTN and ROP stage (P = 0.2342). Analysis of stage and zone together showed that infants born to mothers with mHTN were more likely to have ROP at initial examination, after adjustment for gestational age, but not for birth weight. The use of erythropoietin was not associated with ROP zone or stage, even after adjustment for maternal condition, infant birth weight, or gestational age.
  
  
  CONCLUSIONS
  Although larger avascular areas or higher severity scores were associated with mHTN after adjustment for gestational age at initial examination, no associations were found between mHTN and ROP severity score at the examination when ROP was most severe. There were no associations between ROP severity and treatment with erythropoietin.
authors.affiliation: Department of Ophthalmology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.
authors.forename: Mohamed A
authors.initials: MA
authors.lastname: Zayed
authors.forename: Abhineet
authors.initials: A
authors.lastname: Uppal
authors.forename: M Elizabeth
authors.initials: ME
authors.lastname: Hartnett
mesh_terms: D000751:Anemia, Neonatal / Q000517:prevention & control; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000008:administration & dosage; D005260:Female; D005865:Gestational Age; D006801:Humans; D046110:Hypertension, Pregnancy-Induced / Q000175:diagnosis / Q000209:etiology*; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D011247:Pregnancy; D011994:Recombinant Proteins; D012178:Retinopathy of Prematurity / Q000145:classification / Q000175:diagnosis / Q000209:etiology*; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D011994:Recombinant Proteins; D004921:Erythropoietin
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004863
references.pmid: 16856062
references.citation: N Engl J Med. 2004 Feb 12;350(7):672-83
references.pmid: 14764923
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004865
references.pmid: 16856063
references.citation: Reprod Biol Endocrinol. 2009 Jul 14;7:70
references.pmid: 19602262
references.citation: Exp Eye Res. 2006 Sep;83(3):473-83
references.pmid: 16750526
references.citation: Semin Perinatol. 2000 Feb;24(1):24-8
references.pmid: 10709854
references.citation: Am J Obstet Gynecol. 2007 Oct;197(4):418.e1-5
references.pmid: 17904985
references.citation: J Matern Fetal Neonatal Med. 2008 Jan;21(1):9-23
references.pmid: 18175241
references.citation: Arch Ophthalmol. 2003 Dec;121(12):1684-94
references.pmid: 14662586
references.citation: N Engl J Med. 2003 Jul 31;349(5):427-34
references.pmid: 12890841
references.citation: J Clin Endocrinol Metab. 2009 Jul;94(7):2252-4
references.pmid: 19584199
references.citation: Ophthalmologica. 2000;214(2):131-5
references.pmid: 10720918
references.citation: J AAPOS. 2006 Apr;10(2):143-9
references.pmid: 16678749
references.citation: J Clin Invest. 2003 Mar;111(5):649-58
references.pmid: 12618519
references.citation: J AAPOS. 2008 Jun;12(3):233-8
references.pmid: 18589385
references.citation: Arch Ophthalmol. 1994 Jul;112(7):903-12
references.pmid: 8031269
references.citation: Pediatrics. 2009 Apr;123(4):e638-45
references.pmid: 19289449
references.citation: Clin Sci (Lond). 1998 Aug;95(2):115-28
references.pmid: 9680492
references.citation: J Perinatol. 2009 Oct;29(10):680-4
references.pmid: 19609308
references.citation: J Clin Invest. 2008 Feb;118(2):526-33
references.pmid: 18219389
references.citation: Prenat Diagn. 2008 Sep;28(9):852-8
references.pmid: 18702104
references.citation: Ann Acad Med Singap. 2005 Mar;34(2):169-78
references.pmid: 15827664
references.citation: Pediatrics. 2006 Feb;117(2):572-6
references.pmid: 16452383
references.citation: Lancet. 2000 Oct 7;356(9237):1260-5
references.pmid: 11072961
references.citation: Lancet. 1997 Jul 5;350(9070):12-4
references.pmid: 9217713
references.citation: Am J Perinatol. 1990 Jan;7(1):23-5
references.pmid: 2294905
references.citation: Am J Obstet Gynecol. 2007 Apr;196(4):396.e1-7; discussion 396.e7
references.pmid: 17403433
references.citation: Br J Ophthalmol. 1984 Oct;68(10):690-7
references.pmid: 6548150